Considering the rising demand for biologics, innovators in the biopharmaceutical industry are constantly exploring avenues that would enable them to overcome the existing technical and operational challenges related to viral clearance testing for timely approval of biologics. Outsourcing the viral clearance testing studies has emerged as a promising alternative for most of the manufacturers. Despite